KVUE240719C22000
- 0.01
- 0.000.00%
Kenvue Newsroom
Kenvue Inc. (NYSE:KVUE) Shares Could Be 36% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Kenvue is US$28.75 based on 2 Stage Free Cash Flow to Equity Kenvue's US$18.32 share price signals that it might be 36% undervalued Our fair value
JPMorgan Adjusts Price Target on Kenvue to $22 From $23
Kenvue (KVUE) has an average outperform rating and price target range of $18 to $25.50, according to analysts polled by Capital IQ.Price: 18.60, Change: +0.16, Percent Change: +0.87
Express News | Kenvue Inc : JP Morgan Cuts Target Price to $22 From $23
Goldman Sachs Adjusts Price Target on Kenvue to $19 From $21, Maintains Neutral Rating
Kenvue (KVUE) has an average rating of outperform and price targets ranging from $18 to $25.50, according to analysts by Capital IQ.Price: 18.24, Change: +0.13, Percent Change: +0.72
UBS Maintains Kenvue(KVUE.US) With Hold Rating, Cuts Target Price to $20
UBS analyst Peter Grom maintains $Kenvue(KVUE.US)$ with a hold rating, and adjusts the target price from $21 to $20.According to TipRanks data, the analyst has a success rate of 59.2% and a total
Express News | Kenvue Inc : UBS Cuts Target Price to $20 From $22
Daily short sale tracking: Bank Bradesco SA(prefer share ADS)'s short volume increased by 3 million, with a short sale ratio of 14%
Bank Bradesco SA(prefer share ADS)(BBD.US) ranked top of the list had the largest change in short volume (3.11 million shares), and the short volume ratio of Coty Inc(COTY.US) reached 38.96%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Piper Sandler Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $20
Piper Sandler analyst Korinne Wolfmeyer maintains $Kenvue(KVUE.US)$ with a hold rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 39.7% and
Piper Sandler Remains a Hold on Kenvue, Inc. (KVUE)
Kenvue Is Maintained at Neutral by Citigroup
Kenvue Is Maintained at Neutral by
Express News | Citigroup Maintains Neutral on Kenvue, Lowers Price Target to $20
Kenvue Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 11.86% Citigroup $21 → $20 Maintains Neutral 05/28/2024 17.45% Citigroup → $21 Reinstates
BofA Securities Maintains Kenvue(KVUE.US) With Buy Rating
BofA Securities analyst Anna Lizzul maintains $Kenvue(KVUE.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 47.1% and a total average return of 19.8% over the
Kenvue, Inc. (KVUE): New Buy Recommendation for This Technology Giant
Citi Maintains Kenvue(KVUE.US) With Hold Rating, Cuts Target Price to $20
Citi analyst Filippo Falorni maintains $Kenvue(KVUE.US)$ with a hold rating, and adjusts the target price from $21 to $20.According to TipRanks data, the analyst has a success rate of 63.1% and a
Press Release: Kenvue to Announce Second Quarter 2024 Results on August 6, 2024
Kenvue to Announce Second Quarter 2024 Results on August 6, 2024 SKILLMAN, N.J.--(BUSINESS WIRE)--July 10, 2024-- Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world's largest pure-play consumer health
Express News | Kenvue Inc : Citigroup Cuts Target Price to $20 From $21
RBC Capital Maintains Kenvue(KVUE.US) With Buy Rating, Maintains Target Price $24
RBC Capital analyst Nik Modi maintains $Kenvue(KVUE.US)$ with a buy rating, and maintains the target price at $24.According to TipRanks data, the analyst has a success rate of 57.1% and a total
Kenvue, Inc. (KVUE) Gets a Buy From RBC Capital
Small, Mid-size Biotechs Could See M&A Action in H2 - PwC